nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
|
Juan, Oscar |
|
2017 |
18 |
6 |
p. 595-606 12 p. |
artikel |
2 |
Access to Cancer Specialist Care and Treatment in Patients With Advanced Stage Lung Cancer
|
Ganti, Apar Kishor |
|
2017 |
18 |
6 |
p. 640-650.e2 64361 p. |
artikel |
3 |
A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation–Positive Nonsquamous Non–Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Study
|
Hayashi, Hidetoshi |
|
2017 |
18 |
6 |
p. 719-723 5 p. |
artikel |
4 |
A Randomized, Placebo-Controlled, Phase 1b/2 Study of Rilotumumab or Ganitumab in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive-Stage Small-Cell Lung Cancer
|
Glisson, Bonnie |
|
2017 |
18 |
6 |
p. 615-625.e8 6.2499999386E10 p. |
artikel |
5 |
Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation
|
Oya, Yuko |
|
2017 |
18 |
6 |
p. 698-705.e2 69803 p. |
artikel |
6 |
Attitudes About Lung Cancer Screening: Primary Care Providers Versus Specialists
|
Rajupet, Sritha |
|
2017 |
18 |
6 |
p. e417-e423 nvt p. |
artikel |
7 |
Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study
|
Jiang, Tao |
|
2017 |
18 |
6 |
p. 631-639.e2 63270 p. |
artikel |
8 |
Coexistence of EGFR, KRAS, BRAF, and PIK3CA Mutations and ALK Rearrangement in a Comprehensive Cohort of 326 Consecutive Spanish Nonsquamous NSCLC Patients
|
Martín Martorell, Paloma |
|
2017 |
18 |
6 |
p. e395-e402 nvt p. |
artikel |
9 |
Comparison of Radiotherapy and Chemoradiotherapy for Locoregional Recurrence of Non–small-cell Lung Cancer Developing After Surgery
|
Nakamichi, Shinji |
|
2017 |
18 |
6 |
p. e441-e448 nvt p. |
artikel |
10 |
Computed Tomography Features of Lung Adenocarcinomas With Programmed Death Ligand 1 Expression
|
Toyokawa, Gouji |
|
2017 |
18 |
6 |
p. e375-e383 nvt p. |
artikel |
11 |
Consequences of Referral Time and Volume Doubling Time in Inoperable Patients With Early Stage Lung Cancer
|
Frelinghuysen, Michael |
|
2017 |
18 |
6 |
p. e403-e409 nvt p. |
artikel |
12 |
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib Treatment
|
Bordi, Paola |
|
2017 |
18 |
6 |
p. 692-697 6 p. |
artikel |
13 |
Editorial Board
|
|
|
2017 |
18 |
6 |
p. A1- 1 p. |
artikel |
14 |
Effects of Histamine 2-receptor Antagonists and Proton Pump Inhibitors on the Pharmacokinetics of Gefitinib in Patients With Non–small-cell Lung Cancer
|
Yokota, Hayato |
|
2017 |
18 |
6 |
p. e433-e439 nvt p. |
artikel |
15 |
Evaluating the Genomic Yield of a Single Endobronchial Ultrasound-guided Transbronchial Needle Aspiration in Lung Cancer: Meeting the Challenge of Doing More With Less
|
Leong, Tracy L. |
|
2017 |
18 |
6 |
p. e467-e472 nvt p. |
artikel |
16 |
External Validation of the New International Association for the Study of Lung Cancer Tumor, Node, and Metastasis 8th Edition Staging System and Updated T Descriptors in Determining Prognosis for Patients With Non–Small Cell Lung Cancer Patients With N3 Disease
|
Shin, Jacob Y. |
|
2017 |
18 |
6 |
p. e481-e489 nvt p. |
artikel |
17 |
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer
|
Sakamoto, Shinjiro |
|
2017 |
18 |
6 |
p. e385-e394 nvt p. |
artikel |
18 |
Genomic Profiling of Advanced Non–Small Cell Lung Cancer in Community Settings: Gaps and Opportunities
|
Gutierrez, Martin E. |
|
2017 |
18 |
6 |
p. 651-659 9 p. |
artikel |
19 |
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non–Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis
|
Ahmed, Hiba Z. |
|
2017 |
18 |
6 |
p. 706-718 13 p. |
artikel |
20 |
Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples
|
Casadevall, David |
|
2017 |
18 |
6 |
p. 682-691.e5 6.9099319E7 p. |
artikel |
21 |
Impact of Omission of Intrapulmonary Lymph Node Retrieval on Outcome Evaluation of Lung Cancer Patients Without Lymph Node Metastasis: A Propensity Score Matching Analysis
|
Wang, Xing |
|
2017 |
18 |
6 |
p. e411-e416 nvt p. |
artikel |
22 |
Local Therapy for Oligoprogressive Disease in Patients With Advanced Stage Non–small-cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutation
|
Qiu, Bo |
|
2017 |
18 |
6 |
p. e369-e373 nvt p. |
artikel |
23 |
Outcomes of Stereotactic Body Radiotherapy for T1-T2N0 Small Cell Carcinoma According to Addition of Chemotherapy and Prophylactic Cranial Irradiation: A Multicenter Analysis
|
Verma, Vivek |
|
2017 |
18 |
6 |
p. 675-681.e1 6136 p. |
artikel |
24 |
Prognostic Impact of Minimal Pericardial Effusion in Patients With Advanced Non–small-cell Lung Cancer
|
Kato, Ryoji |
|
2017 |
18 |
6 |
p. e449-e455 nvt p. |
artikel |
25 |
Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement
|
Quintanal-Villalonga, Álvaro |
|
2017 |
18 |
6 |
p. 667-674.e1 6074 p. |
artikel |
26 |
Prognostic Value of Geriatric 8 and Identification of Seniors at Risk for Hospitalized Patients Screening Tools for Patients With Lung Cancer
|
Schulkes, Karlijn J.G. |
|
2017 |
18 |
6 |
p. 660-666.e1 6001 p. |
artikel |
27 |
Programmed Death Ligand 1 Expression in Paired Non–Small Cell Lung Cancer Tumor Samples
|
Cho, Jong Ho |
|
2017 |
18 |
6 |
p. e473-e479 nvt p. |
artikel |
28 |
Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy
|
Moran, Angel |
|
2017 |
18 |
6 |
p. e425-e431 nvt p. |
artikel |
29 |
Systematic Review of Brain Metastases in Patients With Non–Small-Cell Lung Cancer in the United States, European Union, and Japan
|
Fenske, D. Christian |
|
2017 |
18 |
6 |
p. 607-614 8 p. |
artikel |
30 |
Table of Contents
|
|
|
2017 |
18 |
6 |
p. A3-A8 nvt p. |
artikel |
31 |
Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials
|
Garcia, Sandra |
|
2017 |
18 |
6 |
p. 626-630 5 p. |
artikel |
32 |
Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non–small-cell Lung Cancer
|
Chen, Kezhong |
|
2017 |
18 |
6 |
p. e457-e466 nvt p. |
artikel |